Trisomy 21 as the sole acquired karyotypic abnormality in acute myeloid leukemia and myelodysplastic syndrome

Leukemia Research

Volumn 23, Issue 11, 1999, Pages 1079-1083

  Wan, T S K ^a   Au, W Y ^a   Chan, J C W ^b   Chan, L C ^a   Ma, S K ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Acute myeloid leukemia; Cytogenetics; Myelodysplastic syndrome; Pathogenesis; Trisomy 21

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW EXAMINATION; CLINICAL ARTICLE; CYTOGENETICS; DISEASE SEVERITY; FEMALE; HUMAN; KARYOTYPE; LEUKEMOGENESIS; MALE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTOPENIA; TRISOMY 21;

EID: 0032832959     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00117-4     Document Type: Article

References (26)

1. Cortes J.E., Kantarjian H., O'Brien S., Keating M., Pierce S., Freireich E.J. et al. Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes. Leukemia. 9:1995;115.
2. Dewald G.W., Diez-Martin J.L., Steffen S.L., Jenkins R.B., Stupca P.J., Burgert Jr E.O. Hematologic disorders in 13 patients with acquired trisomy 21 and 13 individuals with Down syndrome (supplement). Am. J. Med. Genet. 7:1990;247.
3. Arthur D.C., Berger R., Golomb H.M., Swansbury G.J., Reeves B.R., Alimena G. et al. The clinical significance of karyotype in acute myelogenous leukemia. Cancer Genet. Cytogenet. 40:1989;203.
4. Ma S.K., Ha S.Y., Chan G.C.F., Ching L.M., Lau Y.L., Chan L.C. Cytogenetic abnormalities in pediatric myelodysplastic syndrome: a report of three cases. Cancer Genet. Cytogenet. 93:1997;172.
5. Shen J.J., Williams B.J., Zipursky A., Doyle J., Sherman S.L., Jacobs P.A. et al. Cytogenetic and molecular studies of Down syndrome individuals with leukemia. Am. J. Hum. Genet. 56:1995;915.
6. Brodeur G.M., Dahl G.V., Williams D.L., Tipton R.E., Kalwinsky D.K. Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn. Blood. 55:1980;691.
7. Rowley J.D. Down syndrome and acute leukaemia: increased risk may be due to trisomy 21. Lancet. 2:1981;1020.
8. Hecht F. Leukemia and chromosome 21. Lancet. 1:1982;286.
9. Bartsocas C.S., Athanasiou K. Leukaemia and chromosome 21. Lancet. 1:1982;287.
10. Sacchi N. Down syndrome and chromosome 21 abnormalities in leukemia. Baillière. Clin. Haematol. 5:1992;815.
11. Mitelman F., Levan G. Clustering of aberrations to specific chromosomes in human neoplasm. IV. A survey of 1871 cases. Hereditas. 95:1981;79.
12. Ives J.H., Dagna-Bricarelli F., Basso G., Antonarakis S.E., Jee R., Cotter F. et al. Increased levels of a chromosome 21-encoded tumour inversion and metastasis factor (TIAM1) mRNA in bone marrow of Down syndrome children during the acute phase of AML (M7). Genes Chromosom. Cancer. 23:1998;61.
13. Chen H.M., Antonarakis S.E. Localization of a human homolog of the mouse Tiam-1 gene to chromosome 21q22.1. Genomics. 30:1995;123.
14. Abe K., Kajii T., Niikawa N. Disomic homozygosity in 2-trisomic cells: a mechanism responsible for transient myeloproliferative syndrome. Hum. Genet. 82:1989;313.
15. Niikawa N., Deng H-X., Abe K., Harada N., Okada T., Tsuchiya H. et al. Possible mapping of the gene for transient myeloproliferative syndrome at 21q11.2. Hum. Genet. 87:1991;561.
16. Dagna-Bricarelli F., Argusti A., Cavani S., Pierluigi M., Perfumo C., Perroni L. et al. Molecular study of the 17 DS families with leukemia using polymorphic markers from chromosome 21. Cytogenet. Cell. Genet. 77(Suppl 1):1997;31.
17. Ohta T., Nakano M., Tsujita T., Abe K., Osoegawa K., Yamagata T. et al. Isolation of a cosmid clone corresponding to an inv(21) breakpoint of a patient with transient abnormal myelopoiesis. Am. J. Hum. Genet. 58:1996;544.
18. Groet J., Ives J.H., South A.P., Baptista P.R., Jones T.A., Yaspo M-L. et al. Bacterial contig map of the 21q11 region associated with Alzheimer's disease and abnormal myelopoiesis in Down syndrome. Genome Res. 8:1998;385.
19. Mitelman F., Heim S., Mandahl N. Trisomy 21 in neoplastic cells (supplement). Am. J. Med. Genet. 7:1990;262.
20. Mitelman F. Catalog of chromosome aberrations in cancer. 1994;Wiley-Liss, New York.
21. Wei C-H., Yu I-T., Tseng C-H., Fan F.S., Hsieh R-K., Chiou T-J. Trisomy 21 in acute myeloid leukemia. Cancer Genet. Cytogenet. 86:1996;177.
22. Hoffman R. Acquired pure amegakaryocytic thrombocytopenic purpura. Semin. Hematol. 28:1991;303.
23. Stoll D.B., Blum S., Pasquace D., Murphy S. Thrombocytopenia associated with decreased megakaryocytes. Ann. Intern. Med. 94:1981;170.
24. Johansson B., Mertens F., Mitelman F. Primary vs. secondary neoplasia-associated chromosomal abnormalities - balanced rearrangements vs. genomic imbalances? Genes Chromosom. Cancer. 16:1996;155.
25. Loncarevic I.F., Roitaheim B., Ritterbach J., Viehmann S., Borkhardt A., Lampert F. et al. Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion. Genes. Chromosom. Cancer. 24:1999;272.
26. Martineau M., Greaves M., Bennett C.F., Butler T.A., Jalali G.R., Kasprzyk A. et al. Cytogenetic pointers to the t(12;21) translocation. Blood. 92(Suppl 1):1998;392a.